Global and China Cancer Therapeutics and Biotherapeutics Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Therapeutics and Biotherapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Chemotherapy
1.2.3 Radiation Therapy
1.2.4 Hormone Therapy
1.2.5 Biotherapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cancer Therapeutics and Biotherapeutics Market Share by Application: 2020 VS 2026
1.3.2 Household
1.3.3 Hospital
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Therapeutics and Biotherapeutics Market Perspective (2015-2026)
2.2 Global Cancer Therapeutics and Biotherapeutics Growth Trends by Regions
2.2.1 Cancer Therapeutics and Biotherapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cancer Therapeutics and Biotherapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Cancer Therapeutics and Biotherapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Therapeutics and Biotherapeutics Players by Market Size
3.1.1 Global Top Cancer Therapeutics and Biotherapeutics Players by Revenue (2015-2020)
3.1.2 Global Cancer Therapeutics and Biotherapeutics Revenue Market Share by Players (2015-2020)
3.2 Global Cancer Therapeutics and Biotherapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Therapeutics and Biotherapeutics Revenue
3.4 Global Cancer Therapeutics and Biotherapeutics Market Concentration Ratio
3.4.1 Global Cancer Therapeutics and Biotherapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Therapeutics and Biotherapeutics Revenue in 2019
3.5 Key Players Cancer Therapeutics and Biotherapeutics Area Served
3.6 Key Players Cancer Therapeutics and Biotherapeutics Product Solution and Service
3.7 Date of Enter into Cancer Therapeutics and Biotherapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Therapeutics and Biotherapeutics Breakdown Data by Type (2015-2026)
4.1 Global Cancer Therapeutics and Biotherapeutics Historic Market Size by Type (2015-2020)
4.2 Global Cancer Therapeutics and Biotherapeutics Forecasted Market Size by Type (2021-2026)
5 Cancer Therapeutics and Biotherapeutics Breakdown Data by Application (2015-2026)
5.1 Global Cancer Therapeutics and Biotherapeutics Historic Market Size by Application (2015-2020)
5.2 Global Cancer Therapeutics and Biotherapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cancer Therapeutics and Biotherapeutics Market Size (2015-2026)
6.2 North America Cancer Therapeutics and Biotherapeutics Market Size by Type (2015-2020)
6.3 North America Cancer Therapeutics and Biotherapeutics Market Size by Application (2015-2020)
6.4 North America Cancer Therapeutics and Biotherapeutics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Cancer Therapeutics and Biotherapeutics Market Size (2015-2026)
7.2 Europe Cancer Therapeutics and Biotherapeutics Market Size by Type (2015-2020)
7.3 Europe Cancer Therapeutics and Biotherapeutics Market Size by Application (2015-2020)
7.4 Europe Cancer Therapeutics and Biotherapeutics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Cancer Therapeutics and Biotherapeutics Market Size (2015-2026)
8.2 China Cancer Therapeutics and Biotherapeutics Market Size by Type (2015-2020)
8.3 China Cancer Therapeutics and Biotherapeutics Market Size by Application (2015-2020)
8.4 China Cancer Therapeutics and Biotherapeutics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Cancer Therapeutics and Biotherapeutics Market Size (2015-2026)
9.2 Japan Cancer Therapeutics and Biotherapeutics Market Size by Type (2015-2020)
9.3 Japan Cancer Therapeutics and Biotherapeutics Market Size by Application (2015-2020)
9.4 Japan Cancer Therapeutics and Biotherapeutics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Cancer Therapeutics and Biotherapeutics Market Size (2015-2026)
10.2 Southeast Asia Cancer Therapeutics and Biotherapeutics Market Size by Type (2015-2020)
10.3 Southeast Asia Cancer Therapeutics and Biotherapeutics Market Size by Application (2015-2020)
10.4 Southeast Asia Cancer Therapeutics and Biotherapeutics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Cancer Therapeutics and Biotherapeutics Introduction
11.1.4 AstraZeneca Revenue in Cancer Therapeutics and Biotherapeutics Business (2015-2020))
11.1.5 AstraZeneca Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Cancer Therapeutics and Biotherapeutics Introduction
11.2.4 Bristol-Myers Squibb Revenue in Cancer Therapeutics and Biotherapeutics Business (2015-2020)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Eli Lilly & Company
11.3.1 Eli Lilly & Company Company Details
11.3.2 Eli Lilly & Company Business Overview
11.3.3 Eli Lilly & Company Cancer Therapeutics and Biotherapeutics Introduction
11.3.4 Eli Lilly & Company Revenue in Cancer Therapeutics and Biotherapeutics Business (2015-2020)
11.3.5 Eli Lilly & Company Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Cancer Therapeutics and Biotherapeutics Introduction
11.4.4 Johnson & Johnson Revenue in Cancer Therapeutics and Biotherapeutics Business (2015-2020)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Cancer Therapeutics and Biotherapeutics Introduction
11.5.4 Merck Revenue in Cancer Therapeutics and Biotherapeutics Business (2015-2020)
11.5.5 Merck Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Cancer Therapeutics and Biotherapeutics Introduction
11.6.4 Novartis Revenue in Cancer Therapeutics and Biotherapeutics Business (2015-2020)
11.6.5 Novartis Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Cancer Therapeutics and Biotherapeutics Introduction
11.7.4 Pfizer Revenue in Cancer Therapeutics and Biotherapeutics Business (2015-2020)
11.7.5 Pfizer Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Cancer Therapeutics and Biotherapeutics Introduction
11.8.4 Roche Revenue in Cancer Therapeutics and Biotherapeutics Business (2015-2020)
11.8.5 Roche Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Cancer Therapeutics and Biotherapeutics Introduction
11.9.4 Sanofi Revenue in Cancer Therapeutics and Biotherapeutics Business (2015-2020)
11.9.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Cancer Therapeutics and Biotherapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Radiation Therapy
Table 5. Key Players of Hormone Therapy
Table 6. Key Players of Biotherapy
Table 7. Key Players of Others
Table 8. Global Cancer Therapeutics and Biotherapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Cancer Therapeutics and Biotherapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Cancer Therapeutics and Biotherapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Cancer Therapeutics and Biotherapeutics Market Share by Regions (2015-2020)
Table 12. Global Cancer Therapeutics and Biotherapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Cancer Therapeutics and Biotherapeutics Market Share by Regions (2021-2026)
Table 14. Cancer Therapeutics and Biotherapeutics Market Market Trends
Table 15. Cancer Therapeutics and Biotherapeutics Market Drivers
Table 16. Cancer Therapeutics and Biotherapeutics Market Challenges
Table 17. Cancer Therapeutics and Biotherapeutics Market Restraints
Table 18. Global Cancer Therapeutics and Biotherapeutics Revenue by Players (2015-2020) (US$ Million)
Table 19. Global Cancer Therapeutics and Biotherapeutics Market Share by Players (2015-2020)
Table 20. Global Top Cancer Therapeutics and Biotherapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Therapeutics and Biotherapeutics as of 2019)
Table 21. Global Cancer Therapeutics and Biotherapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cancer Therapeutics and Biotherapeutics Product Solution and Service
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Therapeutics and Biotherapeutics Market Size by Type (2015-2020) (US$ Million)
Table 26. Global Cancer Therapeutics and Biotherapeutics Market Size Share by Type (2015-2020)
Table 27. Global Cancer Therapeutics and Biotherapeutics Revenue Market Share by Type (2021-2026)
Table 28. Global Cancer Therapeutics and Biotherapeutics Market Size Share by Application (2015-2020)
Table 29. Global Cancer Therapeutics and Biotherapeutics Market Size by Application (2015-2020) (US$ Million)
Table 30. Global Cancer Therapeutics and Biotherapeutics Market Size Share by Application (2021-2026)
Table 31. North America Cancer Therapeutics and Biotherapeutics Market Size by Type (2015-2020) (US$ Million)
Table 32. North America Cancer Therapeutics and Biotherapeutics Market Share by Type (2015-2020)
Table 33. North America Cancer Therapeutics and Biotherapeutics Market Size by Application (2015-2020) (US$ Million)
Table 34. North America Cancer Therapeutics and Biotherapeutics Market Share by Application (2015-2020)
Table 35. North America Cancer Therapeutics and Biotherapeutics Market Size by Country (US$ Million) (2015-2020)
Table 36. North America Cancer Therapeutics and Biotherapeutics Market Share by Country (2015-2020)
Table 37. Europe Cancer Therapeutics and Biotherapeutics Market Size by Type (2015-2020) (US$ Million)
Table 38. Europe Cancer Therapeutics and Biotherapeutics Market Share by Type (2015-2020)
Table 39. Europe Cancer Therapeutics and Biotherapeutics Market Size by Application (2015-2020) (US$ Million)
Table 40. Europe Cancer Therapeutics and Biotherapeutics Market Share by Application (2015-2020)
Table 41. Europe Cancer Therapeutics and Biotherapeutics Market Size by Country (US$ Million) (2015-2020)
Table 42. Europe Cancer Therapeutics and Biotherapeutics Market Share by Country (2015-2020)
Table 43. China Cancer Therapeutics and Biotherapeutics Market Size by Type (2015-2020) (US$ Million)
Table 44. China Cancer Therapeutics and Biotherapeutics Market Share by Type (2015-2020)
Table 45. China Cancer Therapeutics and Biotherapeutics Market Size by Application (2015-2020) (US$ Million)
Table 46. China Cancer Therapeutics and Biotherapeutics Market Share by Application (2015-2020)
Table 47. China Cancer Therapeutics and Biotherapeutics Market Size by Region (US$ Million) (2015-2020)
Table 48. China Cancer Therapeutics and Biotherapeutics Market Share by Region (2015-2020)
Table 49. Japan Cancer Therapeutics and Biotherapeutics Market Size by Type (2015-2020) (US$ Million)
Table 50. Japan Cancer Therapeutics and Biotherapeutics Market Share by Type (2015-2020)
Table 51. Japan Cancer Therapeutics and Biotherapeutics Market Size by Application (2015-2020) (US$ Million)
Table 52. Japan Cancer Therapeutics and Biotherapeutics Market Share by Application (2015-2020)
Table 53. Japan Cancer Therapeutics and Biotherapeutics Market Size by Country (US$ Million) (2015-2020)
Table 54. Japan Cancer Therapeutics and Biotherapeutics Market Share by Country (2015-2020)
Table 55. Southeast Asia Cancer Therapeutics and Biotherapeutics Market Size by Type (2015-2020) (US$ Million)
Table 56. Southeast Asia Cancer Therapeutics and Biotherapeutics Market Share by Type (2015-2020)
Table 57. Southeast Asia Cancer Therapeutics and Biotherapeutics Market Size by Application (2015-2020) (US$ Million)
Table 58. Southeast Asia Cancer Therapeutics and Biotherapeutics Market Share by Application (2015-2020)
Table 59. Southeast Asia Cancer Therapeutics and Biotherapeutics Market Size by Country (US$ Million) (2015-2020)
Table 60. Southeast Asia Cancer Therapeutics and Biotherapeutics Market Share by Country (2015-2020)
Table 61. AstraZeneca Company Details
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca Product
Table 64. AstraZeneca Revenue in Cancer Therapeutics and Biotherapeutics Business (2015-2020) (US$ Million)
Table 65. AstraZeneca Recent Development
Table 66. Bristol-Myers Squibb Company Details
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb Product
Table 69. Bristol-Myers Squibb Revenue in Cancer Therapeutics and Biotherapeutics Business (2015-2020) (US$ Million)
Table 70. Bristol-Myers Squibb Recent Development
Table 71. Eli Lilly & Company Company Details
Table 72. Eli Lilly & Company Business Overview
Table 73. Eli Lilly & Company Product
Table 74. Eli Lilly & Company Revenue in Cancer Therapeutics and Biotherapeutics Business (2015-2020) (US$ Million)
Table 75. Eli Lilly & Company Recent Development
Table 76. Johnson & Johnson Company Details
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Product
Table 79. Johnson & Johnson Revenue in Cancer Therapeutics and Biotherapeutics Business (2015-2020) (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. Merck Company Details
Table 82. Merck Business Overview
Table 83. Merck Product
Table 84. Merck Revenue in Cancer Therapeutics and Biotherapeutics Business (2015-2020) (US$ Million)
Table 85. Merck Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Product
Table 89. Novartis Revenue in Cancer Therapeutics and Biotherapeutics Business (2015-2020) (US$ Million)
Table 90. Novartis Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Product
Table 94. Pfizer Revenue in Cancer Therapeutics and Biotherapeutics Business (2015-2020) (US$ Million)
Table 95. Pfizer Recent Development
Table 96. Roche Business Overview
Table 97. Roche Product
Table 98. Roche Company Details
Table 99. Roche Revenue in Cancer Therapeutics and Biotherapeutics Business (2015-2020) (US$ Million)
Table 100. Roche Recent Development
Table 101. Sanofi Company Details
Table 102. Sanofi Business Overview
Table 103. Sanofi Product
Table 104. Sanofi Revenue in Cancer Therapeutics and Biotherapeutics Business (2015-2020) (US$ Million)
Table 105. Sanofi Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Cancer Therapeutics and Biotherapeutics Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Radiation Therapy Features
Figure 4. Hormone Therapy Features
Figure 5. Biotherapy Features
Figure 6. Others Features
Figure 7. Global Cancer Therapeutics and Biotherapeutics Market Share by Application: 2020 VS 2026
Figure 8. Household Case Studies
Figure 9. Hospital Case Studies
Figure 10. Cancer Therapeutics and Biotherapeutics Report Years Considered
Figure 11. Global Cancer Therapeutics and Biotherapeutics Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Cancer Therapeutics and Biotherapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Cancer Therapeutics and Biotherapeutics Market Share by Regions (2021-2026)
Figure 14. Global Cancer Therapeutics and Biotherapeutics Market Share by Players in 2019
Figure 15. Global Top Cancer Therapeutics and Biotherapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Therapeutics and Biotherapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Cancer Therapeutics and Biotherapeutics Revenue in 2019
Figure 17. North America Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Cancer Therapeutics and Biotherapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. AstraZeneca Revenue Growth Rate in Cancer Therapeutics and Biotherapeutics Business (2015-2020)
Figure 45. Bristol-Myers Squibb Revenue Growth Rate in Cancer Therapeutics and Biotherapeutics Business (2015-2020)
Figure 46. Eli Lilly & Company Revenue Growth Rate in Cancer Therapeutics and Biotherapeutics Business (2015-2020)
Figure 47. Johnson & Johnson Revenue Growth Rate in Cancer Therapeutics and Biotherapeutics Business (2015-2020)
Figure 48. Merck Revenue Growth Rate in Cancer Therapeutics and Biotherapeutics Business (2015-2020)
Figure 49. Novartis Revenue Growth Rate in Cancer Therapeutics and Biotherapeutics Business (2015-2020)
Figure 50. Pfizer Revenue Growth Rate in Cancer Therapeutics and Biotherapeutics Business (2015-2020)
Figure 51. Roche Revenue Growth Rate in Cancer Therapeutics and Biotherapeutics Business (2015-2020)
Figure 52. Sanofi Revenue Growth Rate in Cancer Therapeutics and Biotherapeutics Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed